JAMIE KEENE: Open Payments
NPI 1184888661 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 20 payments from 15 companies in 2025. Trend: 2023 $674 · 2024 $394 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| MILLICENT US INC | 2 | $46 |
| ABBVIE INC. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $43 |
| GENZYME CORPORATION | 1 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Organon LLC | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: Mirena, LILETTA, Veozah, CEREZYME, Dexcom G6 Transmitter, NEXPLANON, ABRYSVO, FEMLYV.
Industry payments across FL — which companies pay providers there.
